Fibroblast-derived prolargin is a tumor suppressor in hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fibroblast-derived prolargin is a tumor suppressor in hepatocellular carcinoma

Published:2022-01-14 Issue:10 Volume:41 Page:1410-1420
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Chiavarina Barbara^ORCID,Ronca Roberto^ORCID,Otaka Yukihiro,Sutton Roger Bryan,Rezzola Sara,Yokobori Takehiko,Chiodelli Paola^ORCID,Souche Regis,Pourquier Didier,Maraver Antonio^ORCID,Faa Gavino,Khellaf Lakhdar,Turtoi Evgenia,Oyama Tetsunari,Gofflot Stephanie,Bellahcène Akeila^ORCID,Detry Olivier,Delvenne Philippe,Castronovo Vincent^ORCID,Nishiyama Masahiko,Turtoi Andrei^ORCID

Funder

LabEX MabImprove Starting Grant French National Institute of Health and Medical Research

Fondation de France

Associazione Italiana per la Ricerca sul Cancro

Fondazione Umberto Veronesi

Gunma University

Fondation Contre le Cancer

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

https://www.nature.com/articles/s41388-021-02171-z.pdf

Reference45 articles.

1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–76.

2. Wong MC, Jiang JY, Goggins WB, Liang M, Fang Y, Fung FDH, et al. International incidence and mortality trends of liver cancer: a global profile. Sci Rep. 2017;7:45846.

3. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009;27:1485–91.

4. Morse MA, Sun W, Kim R, He AR, Abada PB, Mynderse M, et al. The Role of Angiogenesis in Hepatocellular Carcinoma. Clin Cancer Res. 2019;25:912–20.

5. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. N. Engl J Med. 2008;359:378–90.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAFs vs. TECs: when blood feuds fuel cancer progression, dissemination and therapeutic resistance;Cellular Oncology;2024-03-07

2. Identification of a Unique Subpopulation of Mucosal Fibroblasts in Colorectal Cancer with Tumor- Restraining Characteristics;2024-02-02

3. Cancer-Associated Fibroblast Heterogeneity in Malignancy with Focus on Oral Squamous Cell Carcinoma;International Journal of Molecular Sciences;2024-01-21

4. The tumor microenvironment in hepatocarcinoma: dissecting the functions of cancer-associated fibroblasts;Hepatoma Research;2023-11-03

5. Dual effects of radiotherapy on tumor microenvironment and its contribution towards the development of resistance to immunotherapy in gastrointestinal and thoracic cancers;Frontiers in Cell and Developmental Biology;2023-10-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3